|
LOC728723 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62625468647093E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.13353770814228E-13 |
| Normal-vs-Stage2 |
2.084000E-03 |
| Normal-vs-Stage3 |
6.31716901011714E-13 |
| Normal-vs-Stage4 |
5.44009282066327E-15 |
| Stage1-vs-Stage2 |
6.581700E-03 |
| Stage1-vs-Stage3 |
1.257650E-01 |
| Stage1-vs-Stage4 |
1.966300E-04 |
| Stage2-vs-Stage3 |
1.182610E-03 |
| Stage2-vs-Stage4 |
2.34709999999971E-05 |
| Stage3-vs-Stage4 |
5.476200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.08500000001377E-06 |
| Normal-vs-Asian |
1.60737000000077E-05 |
| Caucasian-vs-AfricanAmerican |
9.273800E-01 |
| Caucasian-vs-Asian |
2.244500E-02 |
| AfricanAmerican-vs-Asian |
1.504960E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.75430028679114E-10 |
| Normal-vs-Female |
1.62536650805123E-12 |
| Male-vs-Female |
5.862400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.74105174721717E-12 |
| Normal-vs-Age(41-60Yrs) |
2.72619704588806E-11 |
| Normal-vs-Age(61-80Yrs) |
6.30961949354969E-12 |
| Normal-vs-Age(81-100Yrs) |
8.588400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.509800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.509600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.271800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.895800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.869800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.319200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.34120000053295E-07 |
| Classical-VS-Follicular |
9.235800E-04 |
| Classical-VS-Other |
1.564640E-01 |
| Classical-VS-Normal |
1.6304735339645E-12 |
| Tall-VS-Follicular |
6.10119732513681E-11 |
| Tall-VS-Other |
2.802100E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
7.748600E-01 |
| Follicular-VS-Normal |
1.92850999999328E-05 |
| Other-VS-Normal |
1.006180E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.77900044590262E-10 |
| Normal-vs-N1 |
3.29200000592778E-11 |
| N0-vs-N1 |
4.369900E-02 |
|
|
